Robert Benezra
Director/Board Member bei ANGIOGENEX, INC.
Profil
Robert Benezra was the founder of AngioGenex, Inc. which was founded in 1999, where he held the titles of President, Chief Executive Officer & Director from 2014 to 2019.
He is currently a Director at AngioGenex, Inc. and a Professor at Weill Cornell Graduate School of Medical Sciences.
Dr. Benezra's former position was as a Member at Memorial Sloan Kettering Cancer Center.
He received a doctorate degree from The Trustees of Columbia University in The City of New York.
Aktive Positionen von Robert Benezra
| Unternehmen | Position | Beginn |
|---|---|---|
| ANGIOGENEX, INC. | Director/Board Member | - |
| Weill Cornell Graduate School of Medical Sciences | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Robert Benezra
| Unternehmen | Position | Ende |
|---|---|---|
| ANGIOGENEX, INC. | Chief Executive Officer | 12.09.2019 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Robert Benezra
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Health Services |
AngioGenex, Inc.
 AngioGenex, Inc. Pharmaceuticals: MajorHealth Technology AngioGenex, Inc. operates as a biopharmaceutical company, which engages in developing and commercializing novel platform of anti-proliferative drugs for the treatment of cancer and macular degeneration. The company was founded by Michael M. Strage and Robert Benezra in March 1999 and is headquartered in New York, NY. | Health Technology |
